Search Results 1561-1570 of 16136 for chemoprevention

1. Elimination Diet Clinical Trials - Mayo Clinic Research

   The purposes of this study are to to evaluate the use of IgG antibody guided dietary restrictions, based on the Biomerica InFoods® IBS ELISA, in the management ...

2. Dr. John Pemberton on colon cancer and GI problems - Mayo Clinic News Network

   This Mayo Clinic Medical Edge Weekend features Dr. John Pemberton, a Mayo Clinic colon and rectal surgeon, talking about colon cancer and GI problems.

3. An Expanded Access Study of Sofosbuvir Combined with Ribavirin and Either with or without Pegylated Interferon for Treating Aggressive Post-Transplant Hepatitis C - Mayo Clinic

   The purpose of this study, is to open expanded access at specific clinical sites at the request of an investigator for the treatment of individual subjects for ...

4. A Study to Extend the Registry of Inflammatory Diseases of the Central Nervous System - Mayo Clinic

   The purpose of this study is to extend enrollment and follow up of participants in a registry for inflammatory diseases of the central nervous system.

5. Targeting Matrix Metalloproteinases Using Tissue Inhibitors - Proteases in Cancer Laboratory - Mayo Clinic Research

   The Proteases in Cancer Lab of Evette S. Radisky, Ph.D., at Mayo Clinic is developing inhibitors for several MMPs known to promote cancer progression by ...

6. Publications - Bo E. Madsen, M.D., M.P.H. - Mayo Clinic

   Leff R, Madsen BE. Calcium carbonate-associated milk-alkali syndrome as a cause of altered mental status in the emergency department: a case report World J ...

7. Targeting Protease-Activated Receptors (PARs) to Treat Glioblastoma - Projects - Mayo Clinic Research

   Scarisbrick's lab discovered human glioblastoma tumors secrete high levels of serine proteases referred to as kallikreins. Kallikreins are the largest ...

8. Education - Atherosclerosis and Lipid Genomics Laboratory - Mayo Clinic Research

   Contact Dr. Kullo about education opportunities for postdoctoral studies in his Atherosclerosis and Lipid Genomics Lab at Mayo Clinic.

9. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

   A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to ...

10. Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy - Mayo Clinic

    About this study. Pazopanib is FDA approved as a second line and beyond treatment for metastatic soft tissue sarcoma. There is a population of elderly and ...